Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Revised Communication Strategy

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Feb 17, 2024 8:33am

170 Views

Post# 35885666

RE:RE:RE:RE:RE:RE:RE:Revised Communication Strategy

Good point Schmiedly

There's $5.9 million of in the money warrants exercisable within 5 months at .50 that has to factored into "what will Baxter do and when" equation.
Also there, theronostically speaking, is your floor.

Personally I prefer my .48's over these.... but have to wait a bit longer for those to ripen.

MM

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale